Balyasny Asset Management LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$17.63 - $21.74 $354,169 - $436,734
-20,089 Reduced 43.4%
26,200 $516,000
Q4 2023

Feb 14, 2024
BUY
$14.37 - $19.07 $665,172 - $882,731
46,289 New
46,289 $811,000
Q4 2022

Feb 14, 2023
BUY
$11.42 - $17.05 $30,776 - $45,949
2,695 New
2,695 $40,000
Q3 2021

Nov 15, 2021
SELL
$11.39 - $16.23 $4.56 Million - $6.5 Million
-400,296 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$13.22 - $19.09 $5.29 Million - $7.64 Million
400,296 New
400,296 $5.58 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email